STOCK TITAN

[424B2] Citigroup Inc. Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) – Form 4 Insider Transaction filed 07/03/2025

The filing discloses a single transaction by Chief Executive Officer and Director Adam Taylor Sullivan occurring on 07/01/2025. The Form 4 uses transaction code “F”, indicating shares were withheld by the company to satisfy income-tax obligations triggered by the vesting of previously granted restricted stock units (RSUs). A total of 23,508 common shares were withheld at an indicated price of $17.07 per share. No cash proceeds were received by the insider, and the disposition represents less than 1% of his holdings.

After the withholding event, Mr. Sullivan continues to own 4,383,553 shares of Core Scientific common stock in direct form. Footnote 2 clarifies that this figure already includes 4,912 shares distributed in-kind to him on 09/19/2024 from XMS Core Convert Holdings LLC, a transaction previously exempt from Section 16 reporting.

The filing is routine and does not involve the exercise of options, open-market purchases, or sales that would materially affect the public float. It nevertheless confirms that the CEO maintains a sizable equity stake, aligning his incentives with shareholders. From a trading-signal perspective, the share withholding is neutral; it neither increases insider buying conviction nor indicates discretionary selling pressure.

Core Scientific, Inc. (CORZ) – Modulo 4 Transazione Insider presentata il 03/07/2025

La comunicazione rivela una singola transazione effettuata dal CEO e Direttore Adam Taylor Sullivan in data 01/07/2025. Il Modulo 4 utilizza il codice transazione “F”, che indica che le azioni sono state trattenute dall’azienda per soddisfare obblighi fiscali derivanti dal consolidamento di unità azionarie vincolate (RSU) precedentemente assegnate. Sono state trattenute complessivamente 23.508 azioni ordinarie al prezzo indicativo di 17,07 $ per azione. L’insider non ha ricevuto alcun ricavo in contanti e la cessione rappresenta meno dell’1% delle sue partecipazioni.

Dopo questa operazione, il Sig. Sullivan detiene ancora 4.383.553 azioni ordinarie di Core Scientific in forma diretta. La nota 2 specifica che questa cifra include già 4.912 azioni distribuite in natura il 19/09/2024 da XMS Core Convert Holdings LLC, una transazione precedentemente esente dalla segnalazione ai sensi della Sezione 16.

La comunicazione è di routine e non riguarda l’esercizio di opzioni, acquisti sul mercato aperto o vendite che possano influenzare in modo significativo il flottante pubblico. Conferma comunque che il CEO mantiene una consistente partecipazione azionaria, allineando i suoi interessi con quelli degli azionisti. Dal punto di vista del segnale di trading, la trattenuta delle azioni è neutra; non aumenta la fiducia nell’acquisto da parte dell’insider né indica una pressione di vendita discrezionale.

Core Scientific, Inc. (CORZ) – Formulario 4 Transacción de Insider presentada el 03/07/2025

El informe revela una única transacción realizada por el Director Ejecutivo y Director Adam Taylor Sullivan el 01/07/2025. El Formulario 4 utiliza el código de transacción “F”, que indica que la empresa retuvo acciones para cumplir con obligaciones fiscales derivadas de la consolidación de unidades de acciones restringidas (RSU) previamente otorgadas. Se retuvieron un total de 23,508 acciones ordinarias a un precio indicado de $17.07 por acción. El insider no recibió ingresos en efectivo y la disposición representa menos del 1% de sus tenencias.

Después de este evento, el Sr. Sullivan continúa poseyendo 4,383,553 acciones ordinarias de Core Scientific en forma directa. La nota al pie 2 aclara que esta cifra ya incluye 4,912 acciones distribuidas en especie el 19/09/2024 desde XMS Core Convert Holdings LLC, una transacción previamente exenta de reporte bajo la Sección 16.

El informe es rutinario y no involucra el ejercicio de opciones, compras en el mercado abierto o ventas que afecten materialmente el flotante público. Sin embargo, confirma que el CEO mantiene una participación accionaria considerable, alineando sus incentivos con los accionistas. Desde la perspectiva de señales de trading, la retención de acciones es neutral; no aumenta la convicción de compra del insider ni indica presión discrecional de venta.

Core Scientific, Inc. (CORZ) – 2025년 7월 3일 제출된 Form 4 내부자 거래 보고서

이 보고서는 최고경영자 겸 이사인 Adam Taylor Sullivan2025년 7월 1일에 단일 거래를 했음을 공개합니다. Form 4는 거래 코드 “F”를 사용했으며, 이는 회사가 이전에 부여된 제한 주식 단위(RSU)의 권리 확정에 따른 소득세 의무를 충족하기 위해 주식을 원천징수했음을 나타냅니다. 총 23,508 보통주가 주당 $17.07의 가격으로 원천징수되었습니다. 내부자는 현금 수익을 받지 않았으며, 이번 처분은 그의 보유 지분의 1% 미만입니다.

원천징수 후 Sullivan 씨는 직접 형태로 4,383,553주의 Core Scientific 보통주를 계속 보유하고 있습니다. 각주 2는 이 수치에 2024년 9월 19일 XMS Core Convert Holdings LLC에서 그에게 현물로 배분된 4,912주가 이미 포함되어 있으며, 이 거래는 이전에 섹션 16 보고에서 면제되었음을 명확히 합니다.

이 보고서는 일상적인 것으로, 옵션 행사, 공개시장 매수 또는 공공 유통 주식에 중대한 영향을 미칠 판매와 관련이 없습니다. 그럼에도 불구하고 CEO가 상당한 지분을 유지하고 있어 주주와 그의 인센티브가 일치함을 확인해 줍니다. 거래 신호 관점에서 볼 때 주식 원천징수는 중립적이며, 내부자의 매수 확신을 높이지도, 임의 매도 압력을 나타내지도 않습니다.

Core Scientific, Inc. (CORZ) – Déclaration Formulaire 4 d’initié déposée le 03/07/2025

Cette déclaration révèle une transaction unique réalisée par le Directeur Général et Administrateur Adam Taylor Sullivan le 01/07/2025. Le Formulaire 4 utilise le code de transaction « F », indiquant que des actions ont été retenues par la société pour satisfaire à des obligations fiscales liées à l’acquisition de unités d’actions restreintes (RSU) précédemment attribuées. Un total de 23 508 actions ordinaires ont été retenues à un prix indiqué de 17,07 $ par action. L’initié n’a perçu aucun produit en espèces et la disposition représente moins de 1 % de ses avoirs.

Après cet événement, M. Sullivan continue de détenir 4 383 553 actions ordinaires de Core Scientific en direct. La note 2 précise que ce chiffre inclut déjà 4 912 actions qui lui ont été distribuées en nature le 19/09/2024 par XMS Core Convert Holdings LLC, une transaction précédemment exemptée de déclaration en vertu de la Section 16.

La déclaration est de routine et n’implique ni exercice d’options, ni achats sur le marché libre, ni ventes susceptibles d’affecter de manière significative le flottant public. Elle confirme néanmoins que le PDG conserve une participation importante, alignant ainsi ses intérêts avec ceux des actionnaires. Du point de vue du signal de trading, la retenue d’actions est neutre ; elle n’augmente ni la confiance d’achat de l’initié ni ne suggère de pression de vente discrétionnaire.

Core Scientific, Inc. (CORZ) – Form 4 Insider-Transaktion eingereicht am 03.07.2025

Die Meldung offenbart eine einzelne Transaktion des CEO und Direktors Adam Taylor Sullivan am 01.07.2025. Das Formular 4 verwendet den Transaktionscode „F“, was darauf hinweist, dass Aktien vom Unternehmen einbehalten wurden, um Einkommenssteuerverpflichtungen zu erfüllen, die durch die Übertragung zuvor gewährter Restricted Stock Units (RSUs) ausgelöst wurden. Insgesamt wurden 23.508 Stammaktien zu einem angegebenen Preis von 17,07 $ pro Aktie einbehalten. Der Insider erhielt keine Barausschüttung, und die Veräußerung macht weniger als 1 % seines Bestands aus.

Nach dem Einbehalt besitzt Herr Sullivan weiterhin 4.383.553 Aktien der Core Scientific Stammaktien in direkter Form. Fußnote 2 stellt klar, dass diese Zahl bereits 4.912 Aktien umfasst, die ihm am 19.09.2024 von XMS Core Convert Holdings LLC in Sachwerten zugeteilt wurden, eine Transaktion, die zuvor von der Meldepflicht gemäß Abschnitt 16 ausgenommen war.

Die Meldung ist routinemäßig und beinhaltet weder die Ausübung von Optionen noch Käufe am offenen Markt oder Verkäufe, die den Streubesitz wesentlich beeinflussen würden. Sie bestätigt jedoch, dass der CEO eine beträchtliche Aktienbeteiligung hält, wodurch seine Interessen mit denen der Aktionäre in Einklang stehen. Aus handelssignaltechnischer Sicht ist das Einbehalten der Aktien neutral; es erhöht weder die Kaufüberzeugung des Insiders noch deutet es auf einen diskretionären Verkaufsdruck hin.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding sale; CEO still holds 4.38 M shares; negligible impact on valuation or sentiment.

The reported 23,508-share disposition, executed under code “F,” is strictly an administrative step to cover withholding taxes on vested RSUs. At roughly $17 per share, the gross value is about $0.4 million—immaterial relative to Core Scientific’s average daily volume and the CEO’s residual 4.4 million-share stake. Because the shares never entered the open market, there is no incremental supply overhang. Investors should view the transaction as neutral; the CEO’s continued large holding suggests ongoing confidence.

TL;DR: Administrative disposition underscores compliance; insider ownership remains a robust governance positive.

Form 4 filings coded “F” often confuse investors, but they are mandated to ensure transparency when issuers net-settle RSUs. The CEO’s sizeable post-transaction stake (≈5–6% of shares outstanding, depending on current float) reinforces shareholder alignment. No red flags emerge: the filing is timely, complete, and includes proper power-of-attorney signature by the company’s counsel. As such, governance risk remains unchanged.

Core Scientific, Inc. (CORZ) – Modulo 4 Transazione Insider presentata il 03/07/2025

La comunicazione rivela una singola transazione effettuata dal CEO e Direttore Adam Taylor Sullivan in data 01/07/2025. Il Modulo 4 utilizza il codice transazione “F”, che indica che le azioni sono state trattenute dall’azienda per soddisfare obblighi fiscali derivanti dal consolidamento di unità azionarie vincolate (RSU) precedentemente assegnate. Sono state trattenute complessivamente 23.508 azioni ordinarie al prezzo indicativo di 17,07 $ per azione. L’insider non ha ricevuto alcun ricavo in contanti e la cessione rappresenta meno dell’1% delle sue partecipazioni.

Dopo questa operazione, il Sig. Sullivan detiene ancora 4.383.553 azioni ordinarie di Core Scientific in forma diretta. La nota 2 specifica che questa cifra include già 4.912 azioni distribuite in natura il 19/09/2024 da XMS Core Convert Holdings LLC, una transazione precedentemente esente dalla segnalazione ai sensi della Sezione 16.

La comunicazione è di routine e non riguarda l’esercizio di opzioni, acquisti sul mercato aperto o vendite che possano influenzare in modo significativo il flottante pubblico. Conferma comunque che il CEO mantiene una consistente partecipazione azionaria, allineando i suoi interessi con quelli degli azionisti. Dal punto di vista del segnale di trading, la trattenuta delle azioni è neutra; non aumenta la fiducia nell’acquisto da parte dell’insider né indica una pressione di vendita discrezionale.

Core Scientific, Inc. (CORZ) – Formulario 4 Transacción de Insider presentada el 03/07/2025

El informe revela una única transacción realizada por el Director Ejecutivo y Director Adam Taylor Sullivan el 01/07/2025. El Formulario 4 utiliza el código de transacción “F”, que indica que la empresa retuvo acciones para cumplir con obligaciones fiscales derivadas de la consolidación de unidades de acciones restringidas (RSU) previamente otorgadas. Se retuvieron un total de 23,508 acciones ordinarias a un precio indicado de $17.07 por acción. El insider no recibió ingresos en efectivo y la disposición representa menos del 1% de sus tenencias.

Después de este evento, el Sr. Sullivan continúa poseyendo 4,383,553 acciones ordinarias de Core Scientific en forma directa. La nota al pie 2 aclara que esta cifra ya incluye 4,912 acciones distribuidas en especie el 19/09/2024 desde XMS Core Convert Holdings LLC, una transacción previamente exenta de reporte bajo la Sección 16.

El informe es rutinario y no involucra el ejercicio de opciones, compras en el mercado abierto o ventas que afecten materialmente el flotante público. Sin embargo, confirma que el CEO mantiene una participación accionaria considerable, alineando sus incentivos con los accionistas. Desde la perspectiva de señales de trading, la retención de acciones es neutral; no aumenta la convicción de compra del insider ni indica presión discrecional de venta.

Core Scientific, Inc. (CORZ) – 2025년 7월 3일 제출된 Form 4 내부자 거래 보고서

이 보고서는 최고경영자 겸 이사인 Adam Taylor Sullivan2025년 7월 1일에 단일 거래를 했음을 공개합니다. Form 4는 거래 코드 “F”를 사용했으며, 이는 회사가 이전에 부여된 제한 주식 단위(RSU)의 권리 확정에 따른 소득세 의무를 충족하기 위해 주식을 원천징수했음을 나타냅니다. 총 23,508 보통주가 주당 $17.07의 가격으로 원천징수되었습니다. 내부자는 현금 수익을 받지 않았으며, 이번 처분은 그의 보유 지분의 1% 미만입니다.

원천징수 후 Sullivan 씨는 직접 형태로 4,383,553주의 Core Scientific 보통주를 계속 보유하고 있습니다. 각주 2는 이 수치에 2024년 9월 19일 XMS Core Convert Holdings LLC에서 그에게 현물로 배분된 4,912주가 이미 포함되어 있으며, 이 거래는 이전에 섹션 16 보고에서 면제되었음을 명확히 합니다.

이 보고서는 일상적인 것으로, 옵션 행사, 공개시장 매수 또는 공공 유통 주식에 중대한 영향을 미칠 판매와 관련이 없습니다. 그럼에도 불구하고 CEO가 상당한 지분을 유지하고 있어 주주와 그의 인센티브가 일치함을 확인해 줍니다. 거래 신호 관점에서 볼 때 주식 원천징수는 중립적이며, 내부자의 매수 확신을 높이지도, 임의 매도 압력을 나타내지도 않습니다.

Core Scientific, Inc. (CORZ) – Déclaration Formulaire 4 d’initié déposée le 03/07/2025

Cette déclaration révèle une transaction unique réalisée par le Directeur Général et Administrateur Adam Taylor Sullivan le 01/07/2025. Le Formulaire 4 utilise le code de transaction « F », indiquant que des actions ont été retenues par la société pour satisfaire à des obligations fiscales liées à l’acquisition de unités d’actions restreintes (RSU) précédemment attribuées. Un total de 23 508 actions ordinaires ont été retenues à un prix indiqué de 17,07 $ par action. L’initié n’a perçu aucun produit en espèces et la disposition représente moins de 1 % de ses avoirs.

Après cet événement, M. Sullivan continue de détenir 4 383 553 actions ordinaires de Core Scientific en direct. La note 2 précise que ce chiffre inclut déjà 4 912 actions qui lui ont été distribuées en nature le 19/09/2024 par XMS Core Convert Holdings LLC, une transaction précédemment exemptée de déclaration en vertu de la Section 16.

La déclaration est de routine et n’implique ni exercice d’options, ni achats sur le marché libre, ni ventes susceptibles d’affecter de manière significative le flottant public. Elle confirme néanmoins que le PDG conserve une participation importante, alignant ainsi ses intérêts avec ceux des actionnaires. Du point de vue du signal de trading, la retenue d’actions est neutre ; elle n’augmente ni la confiance d’achat de l’initié ni ne suggère de pression de vente discrétionnaire.

Core Scientific, Inc. (CORZ) – Form 4 Insider-Transaktion eingereicht am 03.07.2025

Die Meldung offenbart eine einzelne Transaktion des CEO und Direktors Adam Taylor Sullivan am 01.07.2025. Das Formular 4 verwendet den Transaktionscode „F“, was darauf hinweist, dass Aktien vom Unternehmen einbehalten wurden, um Einkommenssteuerverpflichtungen zu erfüllen, die durch die Übertragung zuvor gewährter Restricted Stock Units (RSUs) ausgelöst wurden. Insgesamt wurden 23.508 Stammaktien zu einem angegebenen Preis von 17,07 $ pro Aktie einbehalten. Der Insider erhielt keine Barausschüttung, und die Veräußerung macht weniger als 1 % seines Bestands aus.

Nach dem Einbehalt besitzt Herr Sullivan weiterhin 4.383.553 Aktien der Core Scientific Stammaktien in direkter Form. Fußnote 2 stellt klar, dass diese Zahl bereits 4.912 Aktien umfasst, die ihm am 19.09.2024 von XMS Core Convert Holdings LLC in Sachwerten zugeteilt wurden, eine Transaktion, die zuvor von der Meldepflicht gemäß Abschnitt 16 ausgenommen war.

Die Meldung ist routinemäßig und beinhaltet weder die Ausübung von Optionen noch Käufe am offenen Markt oder Verkäufe, die den Streubesitz wesentlich beeinflussen würden. Sie bestätigt jedoch, dass der CEO eine beträchtliche Aktienbeteiligung hält, wodurch seine Interessen mit denen der Aktionäre in Einklang stehen. Aus handelssignaltechnischer Sicht ist das Einbehalten der Aktien neutral; es erhöht weder die Kaufüberzeugung des Insiders noch deutet es auf einen diskretionären Verkaufsdruck hin.

The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any state where the offer or sale is not permitted.

SUBJECT TO COMPLETION, DATED JULY 3, 2025

Citigroup Global Markets Holdings Inc.

July----, 2025

Medium-Term Senior Notes, Series N

Pricing Supplement No. 2025-USNCH27470

Filed Pursuant to Rule 424(b)(2)

Registration Statement Nos. 333-270327 and 333-270327-01

Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028

§The securities offered by this pricing supplement are unsecured senior debt securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc.  The securities offer the potential for contingent coupon payments at an annualized rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity. In exchange for this higher potential yield, you must be willing to accept the risks that (i) your actual yield may be lower than the yield on our conventional debt securities of the same maturity because you may not receive one or more, or any, contingent coupon payments; (ii) your actual yield may be negative because, at maturity, you may receive significantly less than the stated principal amount of your securities and possibly nothing; and (iii) the securities may be automatically redeemed prior to maturity. Each of these risks will depend solely on the performance of the worst performing of the underlyings specified below.
§You will be subject to risks associated with each of the underlyings and will be negatively affected by adverse movements in any one of the underlying indices. Although you will have downside exposure to the worst performing underlying, you will not receive dividends with respect to any underlying or participate in any appreciation of any underlying.
§Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations.  All payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.
KEY TERMS
Issuer: Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.
Guarantee: All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.
Underlying indices: Underlying index Initial index level* Coupon barrier level** Final barrier level**
  S&P 500® Index      
  Russell 2000® Index      
  Nasdaq-100 Index®      
 

* For each underlying index, its closing level on the strike date

** For each underlying index, 75.00% of its initial index level

Stated principal amount: $1,000 per security
Strike date: July 11, 2025
Pricing date: July    , 2025 (expected to be July 16, 2025)
Issue date: July    , 2025 (expected to be July 21, 2025)
Interim valuation dates: Expected to be October 16, 2025, January 16, 2026, April 16, 2026, July 16, 2026, October 16, 2026, January 19, 2027, April 16, 2027, July 16, 2027, October 18, 2027, January 18, 2028 and April 17, 2028, each subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur
Final valuation date: Expected to be July 17, 2028, subject to postponement if such date is not a scheduled trading day or if certain market disruption events occur
Maturity date: Unless earlier redeemed, July    , 2028 (expected to be July 20, 2028), subject to postponement as described under “Additional Information” below
Contingent coupon payment dates: For any interim valuation date, the third business day after such interim valuation date; and for the final valuation date, the maturity date
Contingent coupon: On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 2.50% of the stated principal amount of the securities if and only if the relevant index level of the worst performing underlying with respect to the immediately preceding interim valuation date or with respect to the final valuation date, as applicable, is greater than or equal to its coupon barrier level. If the relevant index level of the worst performing underlying with respect to any interim valuation date or the final valuation date, as applicable, is less than its coupon barrier level, you will not receive any contingent coupon payment on the related contingent coupon payment date.
Payment at maturity:

If the securities are not automatically redeemed prior to maturity, you will be entitled to receive at maturity, for each $1,000 stated principal amount security you then hold:

▪ If the final index level of the worst performing underlying on the final valuation date is greater than or equal to its final barrier level: $1,000 plus the contingent coupon payment due at maturity

▪ If the final index level of the worst performing underlying on the final valuation date is less than its final barrier level:

$1,000 + ($1,000 × the index return of the worst performing underlying on the final valuation date)

If the final index level of the worst performing underlying on the final valuation date is less than its final barrier level, you will receive less than 75.00% of the stated principal amount of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment at maturity.

Final index level: For each underlying index, its closing level on the final valuation date
Relevant index level: The relevant index level for each underlying index means (i) with respect to any interim valuation date, its closing level on that interim valuation date and (ii) with respect to the final valuation date, its final index level
Listing: The securities will not be listed on any securities exchange
Underwriter: Citigroup Global Markets Inc. (“CGMI”), an affiliate of the issuer, acting as principal
Underwriting fee and issue price: Issue price(1)(2) Underwriting fee(3) Proceeds to issuer(3)
Per security: $1,000.00 $20.00 $980.00
Total: $ $ $

(1) Citigroup Global Markets Holdings Inc. currently expects that the estimated value of the securities on the pricing date will be at least $926.00 per security, which will be less than the issue price.  The estimated value of the securities is based on CGMI’s proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time after issuance.  See “Valuation of the Securities” in this pricing supplement.

(2) The issue price for investors purchasing the securities in fiduciary accounts is $980.00 per security.

(3) CGMI will receive an underwriting fee of $20.00 for each security sold in this offering.  J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. will act as placement agents for the securities and, from the underwriting fee to CGMI, will receive a placement fee of $20.00 for each security they sell in this offering to accounts other than fiduciary accounts.  CGMI and the placement agents will forgo an underwriting fee and placement fee for sales to fiduciary accounts. For more information on the distribution of the securities, see “Supplemental Plan of Distribution” in this pricing supplement.  In addition to the underwriting fee, CGMI and its affiliates may profit from expected hedging activity related to this offering, even if the value of the securities declines.  See “Use of Proceeds and Hedging” in the accompanying prospectus.  

Investing in the securities involves risks not associated with an investment in conventional debt securities. See “Summary Risk Factors” beginning on page PS-5.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities or determined that this pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are truthful or complete. Any representation to the contrary is a criminal offense.  

You should read this pricing supplement together with the accompanying product supplement, underlying supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks below:

Product Supplement No. EA-04-10 dated March 7, 2023      Underlying Supplement No. 11 dated March 7, 2023

Prospectus Supplement and Prospectus each dated March 7, 2023

The securities are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.

 

Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 
KEY TERMS (continued)
Index return: For each underlying index on an interim valuation date or with respect to the final valuation date, (i) its relevant index level with respect to that interim valuation date or the final valuation date minus its initial index level, divided by (ii) its initial index level
Worst performing underlying: For any interim valuation date or with respect to the final valuation date, the underlying index with the lowest index return determined as of that interim valuation date or the final valuation date
Automatic early redemption: If, on any of the interim valuation dates, the closing level of the worst performing underlying on that interim valuation date is greater than or equal to its initial index level, each security you then hold will be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to $1,000 plus the related contingent coupon payment.
CUSIP / ISIN: 17333LHQ1 / US17333LHQ14

 

 

July 2025PS-2
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Additional Information

 

General. The terms of the securities are set forth in the accompanying product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement, prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, certain events may occur that could affect whether you receive a contingent coupon payment on a contingent coupon payment date or the securities are automatically redeemed as well as your payment at maturity. These events, including market disruption events and other events affecting the underlying indices, and their consequences are described in the accompanying product supplement in the sections “Description of the Securities—Consequences of a Market Disruption Event; Postponement of a Valuation Date” and “Description of the Securities—Certain Additional Terms for Securities Linked to an Underlying Index—Discontinuance or Material Modification of an Underlying Index,” and not in this pricing supplement (except as set forth in the next paragraph). The accompanying underlying supplement contains important disclosures regarding the underlying indices that are not repeated in this pricing supplement. It is important that you read the accompanying product supplement, underlying supplement, prospectus supplement and prospectus together with this pricing supplement in deciding whether to invest in the securities. Certain terms used but not defined in this pricing supplement are defined in the accompanying product supplement.

 

Postponement of the Final Valuation Date; Postponement of the Maturity Date. If the scheduled final valuation date is not a scheduled trading day with respect to an underlying, the final valuation date will be postponed to the next succeeding scheduled trading day with respect to that Underlying. In addition, if a market disruption event occurs with respect to an underlying on the scheduled final valuation date, the calculation agent may, but is not required to, postpone the final valuation date to the next succeeding scheduled trading day for that underlying on which a market disruption event does not occur with respect to that underlying. However, in no event will the final valuation date for an underlying be postponed more than five scheduled trading days after the originally scheduled final valuation date as a result of a market disruption event occurring on the scheduled final valuation date (as it may be postponed). The postponement of the final valuation date for one underlying will not result in the postponement of the final valuation date for any other underlying. If the final valuation date is postponed for an underlying so that it falls less than three business days prior to the scheduled maturity date, the maturity date will be postponed to the third business day after the last final valuation date for an underlying as postponed. The provisions in this paragraph supersede the related provisions in the accompanying product supplement to the extent the provisions in this paragraph are inconsistent with those provisions. The terms “scheduled trading day” and “market disruption event” are defined in the accompanying product supplement. Each interim valuation date is subject to postponement on the terms set forth with respect to valuation dates in the accompanying product supplement.

 

July 2025PS-3
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Hypothetical Examples

 

The table below illustrates various hypothetical payments on the securities at maturity for a range of hypothetical final index levels of the worst performing underlying, assuming the securities are not automatically redeemed.  The outcomes illustrated in the table are not exhaustive, and the actual payment at maturity you receive on the securities may differ from any example illustrated below.

 

The table and examples that follow are based on the following hypothetical values and assumptions in order to illustrate how the securities work and do not reflect the actual initial index levels, coupon barrier levels or final barrier levels. For the actual initial index level, coupon barrier level and final barrier level of each underlying index, see the cover page of this pricing supplement. We have used these hypothetical levels, rather than the actual levels, to simplify the calculations and aid understanding of how the securities work. However, you should understand that the actual payments on the securities will be calculated based on the actual initial index level, coupon barrier level and final barrier level of each underlying index, and not the hypothetical levels indicated below. For ease of analysis, figures below may have been rounded.

 

Underlying index Hypothetical initial index level Hypothetical coupon barrier level Hypothetical final barrier level
S&P 500® Index 100.00 75.00 (75.00% of its hypothetical initial index level) 75.00 (75.00% of its hypothetical initial index level)
Russell 2000® Index 100.00 75.00 (75.00% of its hypothetical initial index level) 75.00 (75.00% of its hypothetical initial index level)
Nasdaq-100 Index® 100.00 75.00 (75.00% of its hypothetical initial index level) 75.00 (75.00% of its hypothetical initial index level)

 

Maturity Date
Hypothetical Final Index Level of Worst Performing Underlying with respect to Final Valuation Date(1) Hypothetical percentage change from initial index level to final index level Hypothetical cash amount you receive at maturity per security(2)
150.00 50.00% $1,025.00
140.00 40.00% $1,025.00
130.00 30.00% $1,025.00
120.00 20.00% $1,025.00
110.00 10.00% $1,025.00
100.00 0.00% $1,025.00
90.00 -10.00% $1,025.00
80.00 -20.00% $1,025.00
75.00 -25.00% $1,025.00
74.99 -25.01% $749.90
70.00 -30.00% $700.00
60.00 -40.00% $600.00
50.00 -50.00% $500.00
40.00 -60.00% $400.00
30.00 -70.00% $300.00
20.00 -80.00% $200.00
10.00 -90.00% $100.00
0.00 -100.00% $0.00

 

(1)The final index level of the worst performing underlying on the final valuation date is equal to its closing level on the final valuation date.  You will be repaid the stated principal amount of your securities if, and only if, the final index level of the worst performing underlying on the final valuation date is greater than or equal to its final barrier level.

 

(2)You will receive a contingent coupon payment at maturity if, and only if, the final index level of the worst performing underlying on the final valuation date is greater than or equal to its coupon barrier level.

 

July 2025PS-4
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Hypothetical Examples of Contingent Coupon Payments and any Payment upon Automatic Early Redemption Following a Valuation Date that is also a Potential Autocall Date

 

The three hypothetical examples below illustrate how to determine whether a contingent coupon will be paid and whether the securities will be automatically redeemed following a hypothetical valuation date that is also a potential autocall date, assuming that the closing levels of the underlying indices on the hypothetical valuation date are as indicated below.

 

  Hypothetical closing level of the S&P 500® Index on hypothetical valuation date Hypothetical closing level of the Russell 2000® Index on hypothetical valuation date Hypothetical closing level of the Nasdaq-100 Index® on hypothetical valuation date Hypothetical payment per $1,000.00 security on related contingent coupon payment date
Example 1 Hypothetical Valuation Date 95
(index return =
(95 - 100) / 100 = -5%)
115
(index return =
(115 - 100) / 100 = 15%)
110
(index return =
(110 - 100) / 100 = 10%)
$25.00
(contingent coupon is paid; securities not redeemed)
Example 2 Hypothetical Valuation Date 150
(index return =
(150 - 100) / 100 = 50%)
45
(index return =
(45 - 100) / 100 = -55%)
80
(index return =
(80 - 100) / 100 = -20%)
$0.00
(no contingent coupon; securities not redeemed)
Example 3 Hypothetical Valuation Date 150
(index return =
(150 - 100) / 100 = 50%)
110
(index return =
(110 - 100) / 100 = 10%)
105
(index return =
(105 - 100) / 100 = 5%)
$1,025.00
(contingent coupon is paid; securities redeemed)

 

Example 1: On the hypothetical valuation date, the S&P 500® Index has the lowest index return and, therefore, is the worst performing underlying on the hypothetical valuation date. In this scenario, the closing level of the worst performing underlying on the hypothetical valuation date is greater than its coupon barrier level but less than its initial index level. As a result, investors in the securities would receive the contingent coupon payment on the related contingent coupon payment date and the securities would not be automatically redeemed.

 

Example 2: On the hypothetical valuation date, the Russell 2000® Index has the lowest index return and, therefore, is the worst performing underlying on the hypothetical valuation date. In this scenario, the closing level of the worst performing underlying on the hypothetical valuation date is less than its coupon barrier level. As a result, investors would not receive any payment on the related contingent coupon payment date and the securities would not be automatically redeemed.

 

Investors in the securities will not receive a contingent coupon on the contingent coupon payment date following a valuation date if the closing level of the worst performing underlying on that valuation date is less than its coupon barrier level.

 

Example 3: On the hypothetical valuation date, the Nasdaq-100 Index® has the lowest index return and, therefore, is the worst performing underlying on the hypothetical valuation date. In this scenario, the closing level of the worst performing underlying on the hypothetical valuation date is greater than both its coupon barrier level and its initial index level. As a result, the securities would be automatically redeemed on the related contingent coupon payment date for an amount in cash equal to $1,000.00 plus the related contingent coupon payment.

 

If the hypothetical valuation date were not also a potential autocall date, the securities would not be automatically redeemed on the related contingent coupon payment date.

 

Hypothetical Examples of the Payment at Maturity on the Securities

 

The next two hypothetical examples illustrate the calculation of the payment at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final index levels of the underlyings are as indicated below.

 

  Hypothetical final index level of the S&P 500® Index Hypothetical final index level of the Russell 2000® Index Hypothetical final index level of the Nasdaq-100 Index® Hypothetical payment at maturity per $1,000.00 security
Example 4 120
(index return =
(120 - 100) / 100 = 20%)
140
(index return =
(140 - 100) / 100 = 40%)
150
(index return =
(150 - 100) / 100 = 50%)

$1,025.00

 

(contingent coupon is paid)

 

Example 5 105
(index return =
(105 - 100) / 100 = 5%)
20
(index return =
(20 - 100) / 100 = -80%)
50
(index return =
(50 - 100) / 100 = -50%)
$200.00

 

July 2025PS-5
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Example 4: On the final valuation date, the S&P 500® Index has the lowest index return and, therefore, is the worst performing underlying on the final valuation date. In this scenario, the final index level of the worst performing underlying on the final valuation date is greater than its final barrier level. Accordingly, at maturity, you would receive the stated principal amount of the securities plus the contingent coupon payment due at maturity, but you would not participate in the appreciation of any of the underlyings.

 

Example 5: On the final valuation date, the Russell 2000® Index has the lowest index return and, therefore, is the worst performing underlying on the final valuation date. In this scenario, the final index level of the worst performing underlying on the final valuation date is less than its final barrier level. Accordingly, at maturity, you would receive a payment per security calculated as follows:

 

Payment at maturity = $1,000 + ($1,000.00 × the index return of the worst performing underlying on the final valuation date)

 

= $1,000 + ($1,000.00 × -75.00%)

 

= $1,000 + -$750.00

 

= $250.00

 

In this scenario, because the final index level of the worst performing underlying on the final valuation date is less than its final barrier level, you would lose a significant portion of your investment in the securities. In addition, because the final index level of the worst performing underlying on the final valuation date is below its coupon barrier level, you would not receive any contingent coupon payment at maturity.

 

It is possible that the relevant index level of the worst performing underlying with respect to each valuation date will be less than its coupon barrier level and less than its final barrier level on the final valuation date, such that you will not receive any contingent coupon payments over the term of the securities and will receive significantly less than the stated principal amount of your securities, and possibly nothing, at maturity.

 

July 2025PS-6
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Summary Risk Factors

 

An investment in the securities is significantly riskier than an investment in conventional debt securities.  The securities are subject to all of the risks associated with an investment in our conventional debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities, and are also subject to risks associated with each underlying index.  Accordingly, the securities are suitable only for investors who are capable of understanding the complexities and risks of the securities.  You should consult your own financial, tax and legal advisors as to the risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.

 

The following is a summary of certain key risk factors for investors in the securities.  You should read this summary together with the more detailed description of risks relating to an investment in the securities contained in the section “Risk Factors Relating to the Securities” beginning on page EA-7 in the accompanying product supplement.  You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.

 

Citigroup Inc. will release quarterly earnings on July 15, 2025, which is during the marketing period and prior to the pricing date of these securities.

 

§You may lose a significant portion or all of your investment.  Unlike conventional debt securities, the securities do not provide for the repayment of the stated principal amount at maturity in all circumstances.  If the securities are not automatically redeemed prior to maturity, your payment at maturity will depend on the final index level of the worst performing underlying. If the final index level of the worst performing underlying is less than its final barrier level, you will lose 1% of the stated principal amount of the securities for every 1% by which the worst performing underlying has declined form its initial index level.  There is no minimum payment at maturity on the securities, and you may lose up to all of your investment.

 

§The initial index level, set on the strike date, may be higher than the closing level of the underlying index on the pricing date. If the closing level of the underlying index on the pricing date is less than the initial index level set on the strike date, the terms of the securities may be less favorable to you than the terms of an alternative investment that may be available to you that offers a similar payout as the securities but with the initial index level set on the pricing date.

 

§You will not receive any contingent coupon payment on any contingent coupon payment date for which the relevant index level of the worst performing underlying with respect to that valuation date is less than its coupon barrier level. A contingent coupon payment will be made on a contingent coupon payment date if and only if the relevant index level of the worst performing underlying for the related valuation date is greater than or equal to its coupon barrier level. If the relevant index level of the worst performing underlying with respect to a valuation date is less than its coupon barrier level, you will not receive any contingent coupon payment on the related contingent coupon payment date. If the relevant index level of the worst performing underlying with respect to each valuation date is below its coupon barrier level, you will not receive any contingent coupon payments over the term of the securities.

 

§Higher contingent coupon rates are associated with greater risk.  The securities offer contingent coupon payments at an annualized rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including the risks that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates, the securities will not be automatically redeemed and the amount you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero. The volatility of, and correlation between, the closing levels of the underlyings are important factors affecting these risks. Greater expected volatility of, and lower expected correlation between, the closing levels of the underlyings as of the pricing date may result in a higher contingent coupon rate, but would also represent a greater expected likelihood as of the pricing date that the relevant index level of the worst performing underlying with respect to one or more valuation dates will be less than its coupon barrier level, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities and that the final index level of the worst performing underlying on the final valuation date will be less than its final barrier level, such that you will not be repaid the stated principal amount of your securities at maturity.

 

§The securities are subject to heightened risk because they have multiple underlyings. The securities are more risky than similar investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying will perform poorly, adversely affecting your return on the securities.

 

§The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs poorly. You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the underlyings is the worst performing underlying.

 

§You will not benefit in any way from the performance of any better performing underlying. The return on the securities depends solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing underlying.

 

July 2025PS-7
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 
§You will be subject to risks relating to the relationship between the underlyings. It is preferable from your perspective for the underlyings to be correlated with each other, in the sense that their closing levels tend to increase or decrease at similar times and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship. The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities. All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict what the relationship between the underlyings will be over the term of the securities. The underlyings differ in significant ways and, therefore, may not be correlated with each other.

 

§Investing in the securities is not equivalent to investing in the underlyings or the stocks that constitute the underlyings. You will not have voting rights, rights to receive dividends or other distributions or any other rights with respect to the stocks that constitute the underlyings. The payment scenarios described in this pricing supplement do not show any effect of lost dividend yield over the term of the securities.

 

§You may not be adequately compensated for assuming the downside risk of the worst performing underlying.  The potential contingent coupon payments on the securities are the compensation you receive for assuming the downside risk of the worst performing underlying, as well as all the other risks of the securities.  That compensation is effectively “at risk” and may, therefore, be less than you currently anticipate.  First, the actual yield you realize on the securities could be lower than you anticipate because the coupon is “contingent” and you may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment dates.  Second, the contingent coupon payments are the compensation you receive not only for the downside risk of the worst performing underlying, but also for all of the other risks of the securities, including the risk that the securities may be automatically redeemed prior to maturity, interest rate risk and our and Citigroup Inc.’s credit risk.  If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon payments may turn out to be inadequate to compensate you for all the risks of the securities, including the downside risk of the worst performing underlying.

 

§The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.  The securities will be automatically redeemed prior to maturity if the closing level of the worst performing underlying on any interim valuation date is greater than or equal to its initial index level. Thus, the term of the securities may be limited to as short as approximately three months. If the securities are automatically redeemed prior to maturity, you will not receive any additional contingent coupon payments. Moreover, you may not be able to reinvest your funds in another investment that provides a similar yield with a similar level of risk.

 

§The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying index.  You will not participate in any appreciation in the level of any underlying index over the term of the securities.  Consequently, your return on the securities will be limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on any underlying index over the term of the securities. In addition, you will not receive any dividends or other distributions or have any other rights with respect to any of the underlyings over the term of the securities.

 

§The performance of the securities will depend on the closing levels of the underlying indices solely on the valuation dates, which makes the securities particularly sensitive to the volatility in the closing levels of the underlying indices on or near the valuation dates.  Whether the contingent coupon will be paid prior to maturity and whether the securities will be automatically redeemed prior to maturity will depend on the closing levels of the underlying indices solely on the applicable valuation dates, regardless of the closing levels of the underlying indices on other days during the term of the securities. If the securities are not automatically redeemed, the amount you receive at maturity will depend solely on the closing level of the worst performing underlying on the final valuation date, and not on any other days during the term of the securities. Because the performance of the securities depends on the closing levels of the underlying indices on a limited number of dates, the securities will be particularly sensitive to volatility in the closing levels of the underlying indices on or near the valuation dates. You should understand that the closing level of each underlying index has historically been highly volatile.

 

§Your payment at maturity depends on the closing level of the worst performing underlying on a single day. Because your payment at maturity depends on the closing level of the worst performing underlying solely on the final valuation date, you are subject to the risk that the closing level of the worst performing underlying on that day may be lower, and possibly significantly lower, than on one or more other dates during the term of the securities. If you had invested in another instrument linked to the worst performing underlying that you could sell for full value at a time selected by you, or if the payment at maturity were based on an average of closing levels of the worst performing underlying, you might have achieved better returns.

 

§The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. If we default on our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you under the securities.

 

§The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.  The securities will not be listed on any securities exchange.  Therefore, there may be little or no secondary market for the securities.  CGMI currently intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily basis.  Any indicative bid price for the securities provided by CGMI will be determined in CGMI’s sole discretion, taking into account prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that price, or at all.  CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for any reason.  If CGMI suspends or terminates making a market, there may be no

 

July 2025PS-8
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

secondary market at all for the securities because it is likely that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity.  Accordingly, an investor must be prepared to hold the securities until maturity.

 

§The estimated value of the securities on the pricing date, based on CGMI’s proprietary pricing models and our internal funding rate, is less than the issue price.  The difference is attributable to certain costs associated with selling, structuring and hedging the securities that are included in the issue price.  These costs include (i) the placement fees paid in connection with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection with hedging our obligations under the securities.  These costs adversely affect the economic terms of the securities because, if they were lower, the economic terms of the securities would be more favorable to you.  The economic terms of the securities are also likely to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities.  See “The estimated value of the securities would be lower if it were calculated based on our secondary market rate” below.

 

§The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.  CGMI derived the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models.  In doing so, it may have made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing levels of the underlying indices, dividend yields on the stocks that constitute the underlying indices and interest rates.  CGMI’s views on these inputs may differ from your or others’ views, and as an underwriter in this offering, CGMI’s interests may conflict with yours.  Both the models and the inputs to the models may prove to be wrong and therefore not an accurate reflection of the value of the securities.  Moreover, the estimated value of the securities set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities for other purposes, including for accounting purposes.  You should not invest in the securities because of the estimated value of the securities. Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.

 

§The estimated value of the securities would be lower if it were calculated based on our secondary market rate.  The estimated value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate, rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity needs and preferences. Our internal funding rate is not the same as the coupon that is payable on the securities.

 

Because there is not an active market for traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject to adjustments that CGMI makes in its sole discretion.  As a result, our secondary market rate is not a market-determined measure of our creditworthiness, but rather reflects the market’s perception of our parent company’s creditworthiness as adjusted for discretionary factors such as CGMI’s preferences with respect to purchasing the securities prior to maturity.

 

§The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you in the secondary market.  Any such secondary market price will fluctuate over the term of the securities based on the market and other factors described in the next risk factor.  Moreover, unlike the estimated value included in this pricing supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market rate, which will likely result in a lower value for the securities than if our internal funding rate were used.  In addition, any secondary market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.  As a result, it is likely that any secondary market price for the securities will be less than the issue price.

 

§The value of the securities prior to maturity will fluctuate based on many unpredictable factors.  The value of your securities prior to maturity will fluctuate based on the level and volatility of the underlyings and a number of other factors, including the price and volatility of the stocks that constitute the underlyings, the dividend yields on the stocks that constitute the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup Inc.’s creditworthiness, as reflected in our secondary market rate. Changes in the level of the underlyings may not result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly less than the issue price.

 

§Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.  The amount of this temporary upward adjustment will steadily decline to zero over the temporary adjustment period.  See “Valuation of the Securities” in this pricing supplement.

 

§The Russell 2000® Index is subject to risks associated with small capitalization stocks. The stocks that constitute the Russell 2000® Index are issued by companies with relatively small market capitalization. The stock prices of smaller

 

July 2025PS-9
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

companies may be more volatile than stock prices of large capitalization companies. These companies tend to be less well-established than large market capitalization companies. Small capitalization companies may be less able to withstand adverse economic, market, trade and competitive conditions relative to larger companies. Small capitalization companies are less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that limits downward stock price pressure under adverse market conditions.

 

§Our offering of the securities does not constitute a recommendation of any underlying index by CGMI or its affiliates or by the placement agents or their affiliates.  The fact that we are offering the securities does not mean that we believe, or that the placement agents or their affiliates believe, that investing in an instrument linked to the underlying indices is likely to achieve favorable returns.  In fact, as we and the placement agents are part of global financial institutions, our affiliates and the placement agents and their affiliates may have positions (including short positions) in the stocks that constitute the underlying indices or in instruments related to the underlying indices or such stocks over the term of the securities, and may publish research or express opinions, that in each case are inconsistent with an investment linked to the underlyings.  These and other activities of our affiliates or the placement agents or their affiliates may affect the level of the underlying indices in a way that has a negative impact on your interests as a holder of the securities.

 

§The closing levels of an underlying index may be adversely affected by our or our affiliates’ hedging and other trading activities. We expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may take positions directly in the stocks that constitute the underlying indices and other financial instruments related to the underlying indices or such stock and may adjust such positions during the term of the securities. Our affiliates and the placement agents and their affiliates also trade the stocks that constitute the underlying indices and other financial instruments related to the underlying indices or such stocks on a regular basis (taking long or short positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities could affect the level of the underlying indices in a way that negatively affects the value of and return on the securities. They could also result in substantial returns for us or our affiliates or the placement agents or their affiliates while the value of the securities declines.

 

§We and our affiliates or the placement agents or their affiliates may have economic interests that are adverse to yours as a result of our affiliates’ or their business activities. Our affiliates or the placement agents or their affiliates may currently or from time to time engage in business with the issuers of the stocks that constitute the underlying indices, including extending loans to, making equity investments in or providing advisory services to such issuers. In the course of this business, we or our affiliates or the placement agents or their affiliates may acquire non-public information about such issuers, which we and they will not disclose to you. Moreover, if any of our affiliates or the placement agents or their affiliates is or becomes a creditor of any such issuer, they may exercise any remedies against such issuer that are available to them without regard to your interests.

 

§The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.  If certain events occur, such as market disruption events or the discontinuance of any underlying index, CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your payment at maturity.  In making these judgments, the calculation agent’s interests as an affiliate of ours could be adverse to your interests as a holder of the securities.

 

§Changes made by the index sponsor may adversely affect the values of the underlyings. We are not affiliated with the index sponsors. Accordingly, we have no control over any changes such sponsor may make to the underlyings. Such changes could be made at any time and could adversely affect the performance of the underlyings.

 

§The U.S. federal tax consequences of an investment in the securities are unclear.  There is no direct legal authority regarding the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the “IRS”).  Consequently, significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as described in “United States Federal Tax Considerations” below.  If the IRS were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition of the securities might be materially and adversely affected.  Moreover, future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment of the securities, possibly retroactively.

 

Non-U.S. investors should note that persons having withholding responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally at a rate of 30%.  To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.

 

You should read carefully the discussion under “United States Federal Tax Considerations” and “Risk Factors Relating to the Securities” in the accompanying product supplement and “United States Federal Tax Considerations” in this pricing supplement.  You should also consult your tax adviser regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

 

July 2025PS-10
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Information About the S&P 500® Index

 

The S&P 500® Index consists of common stocks of 500 issuers selected to provide a performance benchmark for the large capitalization segment of the U.S. equity markets. It is calculated and maintained by S&P Dow Jones Indices LLC. The S&P 500® Index is reported by Bloomberg L.P. under the ticker symbol “SPX.”

 

“Standard & Poor’s,” “S&P” and “S&P 500®” are trademarks of Standard & Poor’s Financial Services LLC and have been licensed for use by Citigroup Inc. and its affiliates. For more information, see “Equity Index Descriptions—The S&P U.S. Indices—License Agreement” in the accompanying underlying supplement.

 

Please refer to the section “Equity Index Descriptions—The S&P U.S. Indices” in the accompanying underlying supplement for important disclosures regarding the S&P 500® Index.

 

Historical Information

 

The closing level of the S&P 500® Index on July 2, 2025 was 6,227.42.

 

The graph below shows the closing level of the S&P 500® Index for each day such level was available from January 2, 2015 to July 2, 2025. We obtained the closing levels from Bloomberg L.P., without independent verification. You should not take the historical levels of the S&P 500® Index as an indication of future performance.

 

S&P 500® Index – Historical Closing Levels*
January 2, 2015 to July 2, 2025

* The red line indicates a hypothetical coupon barrier level and final barrier level with respect to the S&P 500® Index of 4,670.565, assuming its closing level on July 2, 2025 were its initial index level.

 

  

 

July 2025PS-11
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Information About the Russell 2000® Index

 

The Russell 2000® Index is designed to track the performance of the small capitalization segment of the U.S. equity market. All stocks included in the Russell 2000® Index are traded on a major U.S. exchange. It is calculated and maintained by FTSE Russell.

 

Please refer to the section “Equity Index Descriptions— The Russell Indices” in the accompanying underlying supplement for additional information.

 

We have derived all information regarding the Russell 2000® Index from publicly available information and have not independently verified any information regarding the Russell 2000® Index. This pricing supplement relates only to the securities and not to the Russell 2000® Index. We make no representation as to the performance of the Russell 2000® Index over the term of the securities.

 

The securities represent obligations of Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Russell 2000® Index is not involved in any way in this offering and has no obligation relating to the securities or to holders of the securities.

 

Historical Information

 

The closing level of the Russell 2000® Index on July 2, 2025 was 2,226.377.

 

The graph below shows the closing level of the Russell 2000® Index for each day such level was available from January 2, 2015 to July 2, 2025. We obtained the closing level from Bloomberg L.P., without independent verification. You should not take historical closing levels as an indication of future performance.

 

Russell 2000® Index – Historical Closing Levels*
January 2, 2015 to July 2, 2025

* The red line indicates a hypothetical coupon barrier level and final barrier level with respect to the Russell 2000® Index of 1,669.783, assuming its closing level on July 2, 2025 were its initial index level.

 

July 2025PS-12
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

Information About the Nasdaq-100 Index®

 

The Nasdaq-100 Index® is a modified market capitalization-weighted index of stocks of the 100 largest non-financial companies listed on the Nasdaq Stock Market. All stocks included in the Nasdaq-100 Index® are traded on a major U.S. exchange. The Nasdaq-100 Index® was developed by the Nasdaq Stock Market, Inc. and is calculated, maintained and published by Nasdaq, Inc.

 

Please refer to the section “Equity Index Descriptions—The Nasdaq-100 Index®” in the accompanying underlying supplement for additional information.

 

We have derived all information regarding the Nasdaq-100 Index® from publicly available information and have not independently verified any information regarding the Nasdaq-100 Index®. This pricing supplement relates only to the securities and not to the Nasdaq-100 Index®. We make no representation as to the performance of the Nasdaq-100 Index® over the term of the securities.

 

The securities represent obligations of Citigroup Global Markets Holdings Inc. (guaranteed by Citigroup Inc.) only. The sponsor of the Nasdaq-100 Index® is not involved in any way in this offering and has no obligation relating to the securities or to holders of the securities.

 

Historical Information

 

The closing level of the Nasdaq-100 Index® on July 2, 2025 was 22,641.89.

 

The graph below shows the closing level of the Nasdaq-100 Index® for each day such level was available from January 2, 2015 to July 2, 2025. We obtained the closing level from Bloomberg L.P., without independent verification. You should not take historical closing levels as an indication of future performance.

 

Nasdaq-100 Index® – Historical Closing Levels*
January 2, 2015 to July 2, 2025

* The red line indicates a hypothetical coupon barrier level and final barrier level with respect to the Nasdaq-100 Index® of 16,981.418, assuming its closing level on July 2, 2025 were its initial index level.

 

July 2025PS-13
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

United States Federal Tax Considerations

 

You should read carefully the discussion under “United States Federal Tax Considerations” and “Risk Factors Relating to the Securities” in the accompanying product supplement and “Summary Risk Factors” in this pricing supplement.

 

Due to the lack of any controlling legal authority, there is substantial uncertainty regarding the U.S. federal tax consequences of an investment in the securities.  In connection with any information reporting requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of tax accounting.  In the opinion of our counsel, Davis Polk & Wardwell LLP, this treatment of the securities is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively that this treatment is more likely than not to be upheld, and that alternative treatments are possible.  Moreover, our counsel’s opinion is based on market conditions as of the date of this preliminary pricing supplement and is subject to confirmation on the pricing date.

 

Assuming this treatment of the securities is respected and subject to the discussion in “United States Federal Tax Considerations” in the accompanying product supplement, the following U.S. federal income tax consequences should result under current law:

 

·Any coupon payments on the securities should be taxable as ordinary income to you at the time received or accrued in accordance with your regular method of accounting for U.S. federal income tax purposes.

 

·Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference between the amount realized and your tax basis in the security.  For this purpose, the amount realized does not include any coupon paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.  Such gain or loss should be long-term capital gain or loss if you held the security for more than one year.  

 

We do not plan to request a ruling from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts” and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative tax treatments of the securities and potential changes in applicable law.

 

Withholding Tax on Non-U.S. Holders. Because significant aspects of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold.  In order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld and the certification requirement described above.

 

As discussed under “United States Federal Tax Considerations—Tax Consequences to Non-U.S. Holders” in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities (“U.S. Underlying Equities”) or indices that include U.S. Underlying Equities.  Section 871(m) generally applies to instruments that substantially replicate the economic performance of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations.  However, the regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a “delta” of one.  Based on the terms of the securities and representations provided by us as of the date of this preliminary pricing supplement, our counsel is of the opinion that the securities should not be treated as transactions that have a “delta” of one within the meaning of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding tax under Section 871(m).  However, the final determination regarding the treatment of the securities under Section 871(m) will be made as of the pricing date for the securities, and it is possible that the securities will be subject to withholding tax under Section 871(m) based on the circumstances as of that date.

 

A determination that the securities are not subject to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment.  Moreover, Section 871(m) is complex and its application may depend on your particular circumstances, including your other transactions.  You should consult your tax adviser regarding the potential application of Section 871(m) to the securities.

 

We will not be required to pay any additional amounts with respect to amounts withheld.

 

July 2025PS-14
Citigroup Global Markets Holdings Inc.
Autocallable Phoenix Securities Based on the Worst Performing of the S&P 500® Index, the Russell 2000® Index and the Nasdaq-100 Index® Due July   , 2028
 

You should read the section entitled “United States Federal Tax Considerations” in the accompanying product supplement.  The preceding discussion, when read in combination with that section, constitutes the full opinion of Davis Polk & Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing of the securities.

 

You should also consult your tax adviser regarding all aspects of the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

 

Supplemental Plan of Distribution

 

CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $20.00 for each security sold in this offering. The amount of the underwriting fee to CGMI will be equal to the placement fee paid to the placement agents. J.P. Morgan Securities LLC and JPMorgan Chase Bank, N.A. will act as placement agents for the securities and, from the underwriting fee to CGMI, will receive a placement fee of $20.00 for each security they sell in this offering to accounts other than fiduciary accounts. CGMI and the placement agents will forgo an underwriting fee and placement fee for sales to fiduciary accounts.  In addition to the underwriting fee, CGMI and its affiliates may profit from expected hedging activity related to this offering, even if the value of the securities declines. See “Use of Proceeds and Hedging” in the accompanying prospectus. For the avoidance of doubt, the fees and commissions described on the cover of this pricing supplement will not be rebated or subject to amortization if the securities are automatically redeemed.

 

See “Plan of Distribution; Conflicts of Interest” in the accompanying product supplement and “Plan of Distribution” in each of the accompanying prospectus supplement and prospectus for additional information.

 

Valuation of the Securities

 

CGMI calculated the estimated value of the securities set forth on the cover page of this pricing supplement based on proprietary pricing models. CGMI’s proprietary pricing models generated an estimated value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on the securities, which consists of a fixed-income bond (the “bond component”) and one or more derivative instruments underlying the economic terms of the securities (the “derivative component”). CGMI calculated the estimated value of the bond component using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various inputs, including the factors described under “Summary Risk Factors—The value of the securities prior to maturity will fluctuate based on many unpredictable factors” in this pricing supplement, but not including our or Citigroup Inc.’s creditworthiness. These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.

 

The estimated value of the securities is a function of the terms of the securities and the inputs to CGMI’s proprietary pricing models.  As of the date of this preliminary pricing supplement, it is uncertain what the estimated value of the securities will be on the pricing date because it is uncertain what the values of the inputs to CGMI’s proprietary pricing models will be on the pricing date.

 

For a period of approximately six months following issuance of the securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined. This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the six-month temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time. See “Summary Risk Factors—The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.”

 

© 2025 Citigroup Global Markets Inc. All rights reserved. Citi and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the world.

 

July 2025PS-15

FAQ

How many Core Scientific (CORZ) shares does CEO Adam Sullivan now own?

Following the 07/01/2025 transaction, he directly owns 4,383,553 common shares.

Was the July 2025 insider transaction an open-market sale?

No. Code “F” indicates shares were withheld to cover taxes; no open-market activity occurred.

What price was used for the share withholding on 07/01/2025?

The shares were valued at $17.07 per share for withholding purposes.

Does the filing suggest the CEO is selling Core Scientific stock?

The disposition is administrative and not a discretionary sale, so it carries neutral signaling value.

Why does the Form 4 reference 4,912 shares received in September 2024?

Footnote 2 notes those shares were an in-kind distribution from XMS Core Convert Holdings LLC, already included in his total ownership.
Citigroup Inc

NYSE:C

C Rankings

C Latest News

C Latest SEC Filings

C Stock Data

157.93B
1.83B
1.01%
76.85%
1.81%
Banks - Diversified
National Commercial Banks
Link
United States
NEW YORK